Trial Outcomes & Findings for Acceptance-based Group Intervention for Binge Eating (NCT NCT01757847)

NCT ID: NCT01757847

Last Updated: 2016-11-21

Results Overview

This measure contains 16 questions that describe both behavioral and emotional manifestations of a binge episode. This scale was specifically developed to assess binge eating severity and associated emotional distress in overweight and obese individuals. The total score for the measure ranges from 0-46 points with higher scores indicating greater problems with binge eating and lower scores indicating better outcome.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

90 participants

Primary outcome timeframe

post treatment (4 weeks), 3 months, 6 months

Results posted on

2016-11-21

Participant Flow

Participant milestones

Participant milestones
Measure
Brief MOVE-II Active Control Group Intervention
The MOVE-II protocol was designed to reinforce the weight-loss principles that patients learn in MOVE! and to provide support in continued weight loss. The brief MOVE-II active control group protocol was delivered in four 2-hour weekly group sessions. This protocol includes a psycho-educational component that reinforces the key information from the medical, nutrition, and weight loss strategies modules of the MOVE! program. After review of the psycho-educational components, patients have the opportunity to share their challenges with binge eating and weight loss. Patients will then be able to receive support and feedback from other group members and the therapist. In addition, the active control group focuses on increasing self-esteem and self-efficacy.
Acceptance and Commitment Therapy (ACT)
The ACT group protocol consists of four 2-hour weekly sessions focusing on a) thoughts, feelings, and bodily sensations in the context of efforts to lose weight; b) limitations of efforts to control or eliminate negative thoughts or emotions, stress, or food cravings; c) changing expectations and goals from elimination of stress or cravings to living as well as possible with such feelings; d) mindfulness exercises to increase awareness; and e) identification of personal values and goals to achieve improved quality of life.
Overall Study
STARTED
44
46
Overall Study
COMPLETED
41
42
Overall Study
NOT COMPLETED
3
4

Reasons for withdrawal

Reasons for withdrawal
Measure
Brief MOVE-II Active Control Group Intervention
The MOVE-II protocol was designed to reinforce the weight-loss principles that patients learn in MOVE! and to provide support in continued weight loss. The brief MOVE-II active control group protocol was delivered in four 2-hour weekly group sessions. This protocol includes a psycho-educational component that reinforces the key information from the medical, nutrition, and weight loss strategies modules of the MOVE! program. After review of the psycho-educational components, patients have the opportunity to share their challenges with binge eating and weight loss. Patients will then be able to receive support and feedback from other group members and the therapist. In addition, the active control group focuses on increasing self-esteem and self-efficacy.
Acceptance and Commitment Therapy (ACT)
The ACT group protocol consists of four 2-hour weekly sessions focusing on a) thoughts, feelings, and bodily sensations in the context of efforts to lose weight; b) limitations of efforts to control or eliminate negative thoughts or emotions, stress, or food cravings; c) changing expectations and goals from elimination of stress or cravings to living as well as possible with such feelings; d) mindfulness exercises to increase awareness; and e) identification of personal values and goals to achieve improved quality of life.
Overall Study
Withdrawal by Subject
3
4

Baseline Characteristics

Acceptance-based Group Intervention for Binge Eating

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Brief MOVE-II Active Control Group Intervention
n=44 Participants
The MOVE-II protocol was designed to reinforce the weight-loss principles that patients learn in MOVE! and to provide support in continued weight loss. The brief MOVE-II active control group protocol was delivered in four 2-hour weekly group sessions. This protocol includes a psycho-educational component that reinforces the key information from the medical, nutrition, and weight loss strategies modules of the MOVE! program. After review of the psycho-educational components, patients have the opportunity to share their challenges with binge eating and weight loss. Patients will then be able to receive support and feedback from other group members and the therapist. In addition, the active control group focuses on increasing self-esteem and self-efficacy
Acceptance and Commitment Therapy (ACT)
n=46 Participants
The ACT group protocol consists of four 2-hour weekly sessions focusing on a) thoughts, feelings, and bodily sensations in the context of efforts to lose weight; b) limitations of efforts to control or eliminate negative thoughts or emotions, stress, or food cravings; c) changing expectations and goals from elimination of stress or cravings to living as well as possible with such feelings; d) mindfulness exercises to increase awareness; and e) identification of personal values and goals to achieve improved quality of life.
Total
n=90 Participants
Total of all reporting groups
Age, Continuous
57.52 years
STANDARD_DEVIATION 9.33 • n=5 Participants
56.23 years
STANDARD_DEVIATION 10.34 • n=7 Participants
56.87 years
STANDARD_DEVIATION 9.83 • n=5 Participants
Sex: Female, Male
Female
7 Participants
n=5 Participants
13 Participants
n=7 Participants
20 Participants
n=5 Participants
Sex: Female, Male
Male
37 Participants
n=5 Participants
33 Participants
n=7 Participants
70 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=5 Participants
6 Participants
n=7 Participants
8 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
42 Participants
n=5 Participants
40 Participants
n=7 Participants
82 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
10 Participants
n=5 Participants
7 Participants
n=7 Participants
17 Participants
n=5 Participants
Race (NIH/OMB)
White
32 Participants
n=5 Participants
36 Participants
n=7 Participants
68 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Region of Enrollment
United States
44 participants
n=5 Participants
46 participants
n=7 Participants
90 participants
n=5 Participants
Binge Eating Scale
17.48 units on a scale
STANDARD_DEVIATION 8.25 • n=5 Participants
15.53 units on a scale
STANDARD_DEVIATION 9.28 • n=7 Participants
16.47 units on a scale
STANDARD_DEVIATION 8.80 • n=5 Participants

PRIMARY outcome

Timeframe: post treatment (4 weeks), 3 months, 6 months

Population: participants with measurement at baseline and at least one other time point.

This measure contains 16 questions that describe both behavioral and emotional manifestations of a binge episode. This scale was specifically developed to assess binge eating severity and associated emotional distress in overweight and obese individuals. The total score for the measure ranges from 0-46 points with higher scores indicating greater problems with binge eating and lower scores indicating better outcome.

Outcome measures

Outcome measures
Measure
Brief MOVE-II Active Control Group Intervention
n=42 Participants
The MOVE-II protocol was designed to reinforce the weight-loss principles that patients learn in MOVE! and to provide support in continued weight loss. The brief MOVE-II active control group protocol was delivered in four 2-hour weekly group sessions. This protocol includes a psycho-educational component that reinforces the key information from the medical, nutrition, and weight loss strategies modules of the MOVE! program. After review of the psycho-educational components, patients have the opportunity to share their challenges with binge eating and weight loss. Patients will then be able to receive support and feedback from other group members and the therapist. In addition, the active control group focuses on increasing self-esteem and self-efficacy.
Acceptance and Commitment Therapy (ACT)
n=43 Participants
The ACT group protocol consists of four 2-hour weekly sessions focusing on a) thoughts, feelings, and bodily sensations in the context of efforts to lose weight; b) limitations of efforts to control or eliminate negative thoughts or emotions, stress, or food cravings; c) changing expectations and goals from elimination of stress or cravings to living as well as possible with such feelings; d) mindfulness exercises to increase awareness; and e) identification of personal values and goals to achieve improved quality of life.
Change From Baseline in Binge Eating Scale (BES) at 4 Weeks, 3 Months and 6 Months
Baseline
17.38 units on a scale
Standard Deviation 8.15
15.45 units on a scale
Standard Deviation 9.19
Change From Baseline in Binge Eating Scale (BES) at 4 Weeks, 3 Months and 6 Months
Post treatment
10.52 units on a scale
Standard Deviation 7.29
13.52 units on a scale
Standard Deviation 9.05
Change From Baseline in Binge Eating Scale (BES) at 4 Weeks, 3 Months and 6 Months
3 month follow up
10.47 units on a scale
Standard Deviation 7.40
11.90 units on a scale
Standard Deviation 8.65
Change From Baseline in Binge Eating Scale (BES) at 4 Weeks, 3 Months and 6 Months
6 month follow up
10.00 units on a scale
Standard Deviation 7.49
12.20 units on a scale
Standard Deviation 7.32

SECONDARY outcome

Timeframe: post treatment (4 weeks), 3 months, 6 months

Population: Participants with measurement at baseline and at least one other time point.

The ORWELL-97 is a self-report measure of obesity-related quality of life. It has been validated on obese patients. The total score ranges from 0-162 with higher scores indicating lower quality of life and decreasing scores indicating improvement in the outcome.

Outcome measures

Outcome measures
Measure
Brief MOVE-II Active Control Group Intervention
n=42 Participants
The MOVE-II protocol was designed to reinforce the weight-loss principles that patients learn in MOVE! and to provide support in continued weight loss. The brief MOVE-II active control group protocol was delivered in four 2-hour weekly group sessions. This protocol includes a psycho-educational component that reinforces the key information from the medical, nutrition, and weight loss strategies modules of the MOVE! program. After review of the psycho-educational components, patients have the opportunity to share their challenges with binge eating and weight loss. Patients will then be able to receive support and feedback from other group members and the therapist. In addition, the active control group focuses on increasing self-esteem and self-efficacy.
Acceptance and Commitment Therapy (ACT)
n=43 Participants
The ACT group protocol consists of four 2-hour weekly sessions focusing on a) thoughts, feelings, and bodily sensations in the context of efforts to lose weight; b) limitations of efforts to control or eliminate negative thoughts or emotions, stress, or food cravings; c) changing expectations and goals from elimination of stress or cravings to living as well as possible with such feelings; d) mindfulness exercises to increase awareness; and e) identification of personal values and goals to achieve improved quality of life.
Change From Baseline in The Obesity-related Well Being Scale (ORWELL-97) at 4 Weeks, 3 Months, and 6 Months
Baseline
50.17 units on a scale
Standard Deviation 28.26
49.47 units on a scale
Standard Deviation 30.60
Change From Baseline in The Obesity-related Well Being Scale (ORWELL-97) at 4 Weeks, 3 Months, and 6 Months
Post Treatment
41.86 units on a scale
Standard Deviation 22.65
46.02 units on a scale
Standard Deviation 33.57
Change From Baseline in The Obesity-related Well Being Scale (ORWELL-97) at 4 Weeks, 3 Months, and 6 Months
3 month follow up
41.07 units on a scale
Standard Deviation 26.77
38.79 units on a scale
Standard Deviation 29.14
Change From Baseline in The Obesity-related Well Being Scale (ORWELL-97) at 4 Weeks, 3 Months, and 6 Months
6 month follow up
37.90 units on a scale
Standard Deviation 31.87
36.55 units on a scale
Standard Deviation 27.82

Adverse Events

Brief MOVE-II Active Control Group Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Acceptance and Commitment Therapy (ACT)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Niloofar Afari, PhD

VA San Diego Healthcare System

Phone: 858-642-3387

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place